Back to Journals » Biologics: Targets and Therapy » Volume 9

Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

Total article views   HTML views PDF downloads Totals
11,013 Dovepress* 10,567+ 1,768 12,335
PubMed Central* 446 155 601
Totals 11,013 1,923 12,936
*Since 19 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar